Bank Julius Baer & Co. Ltd, Zurich Repligen Corp Transaction History

Bank Julius Baer & Co. Ltd, Zurich

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$161.19 - $257.96 $648,628 - $1.04 Million	-4,024 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$247.59 - $304.47 $996,302 - $1.23 Million	4,024 New	4,024 $1.07 Million
Q2 2021 Jul 23, 2021	SELL	$165.87 - $220.95 $16,587 - $22,095	-100 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$180.37 - $226.26 $27,055 - $33,939	-150 Reduced 60.0%	100 $19,000
Q4 2020 Feb 12, 2021	SELL	$148.08 - $206.57 $51,828 - $72,299	-350 Reduced 58.33%	250 $48,000
Q1 2020 May 13, 2020	BUY	$84.96 - $109.14 $50,975 - $65,484	600 New	600 $58,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.